e-learning
resources
Paris 2018
Sunday, 16.09.2018
New developments in the treatment of asthma
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Consistent efficacy across endpoints with reslizumab despite short term variability in blood eosinophil levels
M. Castro (St Louis, United States of America), Y. Adir (Haifa, Israel), P. Chanez (Marseille, France), M. Mcdonald (Malvern, United States of America), L. Hickey (Malvern, United States of America), M. Garin (Malvern, United States of America)
Source:
International Congress 2018 – New developments in the treatment of asthma
Session:
New developments in the treatment of asthma
Session type:
Thematic Poster
Number:
1043
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Castro (St Louis, United States of America), Y. Adir (Haifa, Israel), P. Chanez (Marseille, France), M. Mcdonald (Malvern, United States of America), L. Hickey (Malvern, United States of America), M. Garin (Malvern, United States of America). Consistent efficacy across endpoints with reslizumab despite short term variability in blood eosinophil levels. 1043
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Blood eosinophils in COPD: long term variability and clinical outcomes
Source: International Congress 2017 – Innovation in COPD: techniques and facts
Year: 2017
Short term reductions in inhaled glucocorticoid doses in children with asthma may be associated with increased levels of serum eosinophil protein X
Source: Eur Respir J 2001; 18: Suppl. 33, 451s
Year: 2001
Consistently low blood lymphocytes in smokers are associated with worse clinical outcomes.
Source: International Congress 2018 – Studying novel biomarkers in asthma and COPD
Year: 2018
Impact of blood eosinophil variability in asthma: a real-life population study.
Source: Virtual Congress 2021 – Clinical features and new biomarkers of asthma, COPD and chronic cough
Year: 2021
A single blood eosinophil count measurement is as good as two for prediction of ICS treatment response in the IMPACT trial
Source: Eur Respir J, 58 (3) 2004522; 10.1183/13993003.04522-2020
Year: 2021
Variability and lack of predictive ability of asthma end-points in clinical trials
Source: Eur Respir J 2002; 20: 1102-1109
Year: 2002
The association of the oxygen saturation level at the time of hospitalization with comorbidities and subsequent changes in blood biomarkers in patients with COVID-19 in Russia: observational study results.
Source: Virtual Congress 2021 – COVID - 19: lessons learned
Year: 2021
Impact of long-term oxygen therapy on morphological changes of red blood cells and NT-proBNP level in COPD patients.
Source: International Congress 2017 – COPD biomarkers
Year: 2017
Lack of seasonal variability of blood eosinophil counts in COPD
Source: International Congress 2019 – Airway diseases and blood cells
Year: 2019
A preliminary study to identify correlations between blood glucose levels and cardiorespiratory observations in acute asthma patients receiving nebulised salbutamol.
Source: Virtual Congress 2021 – Advances in asthma treatment
Year: 2021
Evaluation of the association between eosinophil variability and effects of inhaled corticosteroids in COPD patients using propensity score matching
Source: International Congress 2019 – COPD clinical studies: bronchodilators, corticosteroids and more
Year: 2019
Change in blood eosinophils following treatment with inhaled corticosteroids may predict long-term clinical response in COPD
Source: Eur Respir J, 55 (5) 1902119; 10.1183/13993003.02119-2019
Year: 2020
Correlations between exacerbation rate and blood eosinophil levels in COPD patients
Source: International Congress 2017 – Infection and exacerbation science
Year: 2017
Low versus high Th2 asthma: variability of blood eosinophil counts in a longitudinal analysis
Source: Virtual Congress 2021 – Severe asthma: evaluation using patient-reported outcome measures (PROMs) and biomarkers, comorbidities and treatments
Year: 2021
Intravenous (IV) reslizumab efficacy does not differ by blood eosinophil lowering to levels above or below 50 cells/µL
Source: International Congress 2018 – New developments in the treatment of asthma
Year: 2018
Analysis of IMPACT: is one blood eosinophil count measurement sufficient to predict ICS treatment response in COPD?
Source: International Congress 2019 – COPD clinical trials: new molecules and novel insights
Year: 2019
The effect of statin usage on airway inflammatiory cells and markers, and clinical indices in asthmatic patients
Source: Annual Congress 2011 - Asthma management and response
Year: 2011
The effectiveness of different clinical measures in evaluating response to omalizumab
Source: Annual Congress 2010 - Questionnaires use and psychological aspects in asthma
Year: 2010
A preliminary study to determine the effects of nebulised salbutamol on blood glucose levels during an acute asthma exacerbation.
Source: International Congress 2019 – Asthma: outcomes of clinical trials and cohorts
Year: 2019
Effect of CPAP treatment on endothelial function, inflammatory markers, blood pressure and glucose control in patients with OSAS with emphasis on gender differences
Source: Annual Congress 2011 - Cardiometabolic and neurocognitive changes in obstructive sleep apnoea
Year: 2011
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept